Figure 2 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
<p>Percentage change in Ki67 between pretreatment (baseline) and surgery for part 1 (<b>A</b>) and part 2 (<b>B</b>); Kaplan–Meier estimates by treatment group for relapse free survival (<b>C</b>) and overall survival (<b>D</b>). <b>A,</...
Wedi'i Gadw mewn:
| Prif Awdur: | |
|---|---|
| Awduron Eraill: | , , , , , , , , , , , , , , , , , , , , , |
| Cyhoeddwyd: |
2025
|
| Pynciau: | |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|